Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1985 1
1986 3
1987 2
1989 1
1990 1
1991 7
1992 5
1993 6
1994 8
1995 8
1996 7
1997 9
1998 3
1999 2
2000 10
2001 16
2002 10
2003 11
2004 5
2005 8
2006 5
2007 10
2008 7
2009 7
2010 10
2011 12
2012 4
2013 7
2014 9
2015 7
2016 7
2017 8
2018 7
2019 6
2020 4
2021 11
2022 8
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

249 results

Results by year

Filters applied: . Clear all
Page 1
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update.
Loprinzi CL, Lacchetti C, Bleeker J, Cavaletti G, Chauhan C, Hertz DL, Kelley MR, Lavino A, Lustberg MB, Paice JA, Schneider BP, Lavoie Smith EM, Smith ML, Smith TJ, Wagner-Johnston N, Hershman DL. Loprinzi CL, et al. Among authors: kelley mr. J Clin Oncol. 2020 Oct 1;38(28):3325-3348. doi: 10.1200/JCO.20.01399. Epub 2020 Jul 14. J Clin Oncol. 2020. PMID: 32663120
Azad N, Agrawal L, Emanuele MA, Kelley MR, Mohagheghpour N, Lawrence AM, Emanuele NV. Azad N, et al. Among authors: kelley mr. Am J Reprod Immunol. 1991 Dec;26(4):160-72. doi: 10.1111/j.1600-0897.1991.tb00718.x. Am J Reprod Immunol. 1991. PMID: 1668637 Review. No abstract available.
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease.
Sahakian L, Robinson AM, Sahakian L, Stavely R, Kelley MR, Nurgali K. Sahakian L, et al. Among authors: kelley mr. Biomolecules. 2023 Oct 24;13(11):1569. doi: 10.3390/biom13111569. Biomolecules. 2023. PMID: 38002251 Free PMC article. Review.
Going APE over ref-1.
Evans AR, Limp-Foster M, Kelley MR. Evans AR, et al. Among authors: kelley mr. Mutat Res. 2000 Oct 16;461(2):83-108. doi: 10.1016/s0921-8777(00)00046-x. Mutat Res. 2000. PMID: 11018583 Review.
Seizing Control of KCC2: A New Therapeutic Target for Epilepsy.
Moore YE, Kelley MR, Brandon NJ, Deeb TZ, Moss SJ. Moore YE, et al. Among authors: kelley mr. Trends Neurosci. 2017 Sep;40(9):555-571. doi: 10.1016/j.tins.2017.06.008. Epub 2017 Aug 10. Trends Neurosci. 2017. PMID: 28803659 Review.
Inhibition of PRMT5 by market drugs as a novel cancer therapeutic avenue.
Prabhu L, Martin M, Chen L, Demir Ö, Jin J, Huang X, Motolani A, Sun M, Jiang G, Nakshatri H, Fishel ML, Sun S, Safa A, Amaro RE, Kelley MR, Liu Y, Zhang ZY, Lu T. Prabhu L, et al. Among authors: kelley mr. Genes Dis. 2022 Apr 13;10(1):267-283. doi: 10.1016/j.gendis.2022.04.001. eCollection 2023 Jan. Genes Dis. 2022. PMID: 37013054 Free PMC article.
Discovery of the Migraine Prevention Therapeutic Aimovig (Erenumab), the First FDA-Approved Antibody against a G-Protein-Coupled Receptor.
King CT, Gegg CV, Hu SN, Sen Lu H, Chan BM, Berry KA, Brankow DW, Boone TJ, Kezunovic N, Kelley MR, Shi L, Xu C. King CT, et al. Among authors: kelley mr. ACS Pharmacol Transl Sci. 2019 Sep 3;2(6):485-490. doi: 10.1021/acsptsci.9b00061. eCollection 2019 Dec 13. ACS Pharmacol Transl Sci. 2019. PMID: 32259079 Free PMC article.
249 results